Insider Buy Alert: FMX Director Invests in 2,100 Shares

Source Motley_fool

Key Points

  • The purchase of 2,100 shares was executed at $118.13 per share for a total transaction value of $248,073.

  • This transaction represents the establishment of an initial direct equity position for the director.

  • The securities are held as American Depositary Shares (ADRs), with each ADR representing 10 BD Units consisting of Series B, Series D-B, and Series D-L shares.

  • 10 stocks we like better than Fomento Económico MexicanoB. De C.v. ›

Michael David Kahn, Director at Fomento Económico Mexicano, S.A.B. de C.V. (NYSE:FMX), purchased 2,100 shares of the company's American Depositary Shares on Aug. 11, 2026, according to an SEC Form 4 filing.

Transaction summary

MetricValue
Shares purchased (directly held)2,100
Transaction value$248,073
Post-transaction shares (directly held)2,100
Post-transaction value$248,283

Transaction value based on SEC Form 4 weighted average purchase price ($118.13); post-transaction value based on Aug. 11, 2026 market close ($118.23).

Key questions

  • What is the significance of this transaction for the director's total equity exposure?
    This purchase marks the initiation of a direct equity position for Michael David Kahn, who now holds 2,100 American Depositary Shares (ADRs), with a value of $248,283 based on the Aug. 11, 2026, close.
  • How does the transaction price compare to recent market levels?
    The purchase was executed at $118.13 per share, narrowly below the $118.23 market close on the day of the transaction. The acquisition follows a period of appreciation for the stock, which recorded a 37% return over the 12 months ending Aug. 11, 2026.
  • What business operations does this equity position represent?
    Fomento Económico Mexicano operates as a diversified enterprise, functioning as a primary bottler and distributor for Coca-Cola products across Latin America while managing more than 20,000 OXXO convenience stores in multiple countries.

Company Overview

MetricValue
Share Price (as of market close 2026-08-11)$118.23
Market Capitalization$40.4 billion

Company Snapshot

  • FEMSA operates as a leading bottler, marketer, and distributor of Coca-Cola branded beverages across Latin America and the Caribbean, generating substantial revenue from beverage sales while maintaining a significant retail presence through its OXXO convenience store network across multiple countries.
  • The company generates revenue through two business segments: beverage operations that leverage established distribution networks and brand partnerships, and retail operations through OXXO stores, which serve as both direct revenue sources and distribution channels for beverage products.
  • FEMSA's primary customers include retail establishments, foodservice operators, and individual consumers across Mexico, Central America, South America, and the Caribbean, with particular strength in the Mexican market, where it maintains extensive market penetration.

Fomento Económico Mexicano is a diversified multinational enterprise that operates across Latin America and the Caribbean. The company maintains a competitive advantage through its integrated business model, combining beverage bottling and distribution with a substantial retail footprint of over 20,000 OXXO convenience stores, enabling efficient supply chain management and market access. FEMSA's scale, established distribution infrastructure, and strategic positioning in high-growth emerging markets position it as a dominant player in the non-alcoholic beverage sector across the region.

What this transaction means for investors

FMX has steady work as a franchise bottler for Coca-Cola, producing, marketing, and distributing beverages bearing the Coca-Cola trademark in countries such as Mexico, Colombia, Brazil, Argentina, and Uruguay, just to name a few. In addition, it also runs convenience stores under the OXXO name. Over the last 12 months, FMX shares have performed particularly well, climbing 37.6% as of this writing. In comparison, the S&P 500 is up 19.4% during the same time frame. Of the 20 FMX analysts tracked by CNN, the median one-year price target is $140.13, which would represent a 18% gain if FMX reaches it from its current price. The highest price target is $184.24, while the lowest is $117.21. From that information, there still appears to be more upside ahead and limited downside, according to the expectations from analysts.

According to the SEC Form 4, this appears to be Kahn's first transaction to buy ADR shares. There are many reasons to sell shares, but typically, an insider buys only because they are bullish about the company's future. While investors shouldn't buy shares just because an insider did, it is nice to see a vote of confidence from an insider, as they know what's going on inside the company the best.

Should you buy stock in Fomento Económico MexicanoB. De C.v. right now?

Before you buy stock in Fomento Económico MexicanoB. De C.v., consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Fomento Económico MexicanoB. De C.v. wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $432,621!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,335,314!*

Now, it’s worth noting Stock Advisor’s total average return is 973% — a market-crushing outperformance compared to 213% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of August 20, 2026.

Jack Delaney has no position in any of the stocks mentioned. The Motley Fool recommends Fomento Económico MexicanoB. De C.v. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Why are prediction market traders suddenly bearish on Nvidia's stock?Nvidia (NASDAQ: NVDA) stock is still green for 2026, but the trade no longer looks clean from the company that outperformed every other company and country in 2024 and 2025. NND is up about 12% this year, yet they have slipped roughly 3% over the past month. The gap with the rest of the chip...
Author  Cryptopolitan
Jun 23, Tue
Nvidia (NASDAQ: NVDA) stock is still green for 2026, but the trade no longer looks clean from the company that outperformed every other company and country in 2024 and 2025. NND is up about 12% this year, yet they have slipped roughly 3% over the past month. The gap with the rest of the chip...
placeholder
4 Memory Stocks Cramer Says Could Avoid an AI Bust and Keep ClimbingJim Cramer says four memory chip stocks still have room to climb, even after posting some of 2026’s biggest gains. The Mad Money host argues Micron, SanDisk, Seagate, and Western Digital have broken t
Author  Beincrypto
Aug 19, Wed
Jim Cramer says four memory chip stocks still have room to climb, even after posting some of 2026’s biggest gains. The Mad Money host argues Micron, SanDisk, Seagate, and Western Digital have broken t
placeholder
Elon Musk’s AI Startup Acquisition Fails to Land as Cognition Rebuffs SpaceX BuyoutSpaceX’s attempt to acquire artificial intelligence coding startup Cognition AI Inc. stalled without a deal, according to people familiar with the matter. The approach would have been SpaceX’s second
Author  Beincrypto
Yesterday 01: 41
SpaceX’s attempt to acquire artificial intelligence coding startup Cognition AI Inc. stalled without a deal, according to people familiar with the matter. The approach would have been SpaceX’s second
placeholder
Eli Lilly Price Forecast: The Next Big Stock After Weight-Loss Drug Breakthrough?Eli Lilly is one of the most popular names today in America’s weight-loss and diabetes drug market. Its drugs delivered an average weight loss of 28.3% in a Phase 3 trial, approaching results historic
Author  Beincrypto
Yesterday 01: 51
Eli Lilly is one of the most popular names today in America’s weight-loss and diabetes drug market. Its drugs delivered an average weight loss of 28.3% in a Phase 3 trial, approaching results historic
placeholder
Why the S&P 500’s Path to 9,000 Runs Into Trouble in 2027The boldest S&P 500 forecast on Wall Street sees 9,000 by year-end, roughly 17% above where the index trades now. The fuel is the AI boom and a wall of idle cash.The warning is that the same AI trade
Author  Beincrypto
Yesterday 01: 56
The boldest S&P 500 forecast on Wall Street sees 9,000 by year-end, roughly 17% above where the index trades now. The fuel is the AI boom and a wall of idle cash.The warning is that the same AI trade
goTop
quote